NeoCore Technology Co., Ltd. (4131.TWO)
TWD 31.85
(0.63%)
TWD 31.85
(0.63%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -9.08 Million TWD | -177.1% |
| 2022 | 11.78 Million TWD | -39.26% |
| 2021 | 19.4 Million TWD | 1.98% |
| 2020 | 19.02 Million TWD | -54.33% |
| 2019 | 41.65 Million TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 130 Thousand TWD | 101.88% |
| 2024 Q2 | -1.96 Million TWD | -1613.08% |
| 2023 Q2 | -3.41 Million TWD | -224.18% |
| 2023 Q4 | -6.92 Million TWD | -361.4% |
| 2023 Q1 | 2.74 Million TWD | -59.12% |
| 2023 FY | -9.08 Million TWD | -177.1% |
| 2023 Q3 | -1.5 Million TWD | 56.01% |
| 2022 Q3 | 720 Thousand TWD | 0.0% |
| 2022 FY | 11.78 Million TWD | -39.26% |
| 2022 Q4 | 6.71 Million TWD | 833.06% |
| 2021 FY | 19.4 Million TWD | 1.98% |
| 2020 FY | 19.02 Million TWD | -54.33% |
| 2019 FY | 41.65 Million TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 102.257% |
| Level Biotechnology Inc. | 219.54 Million TWD | 104.138% |
| Sagittarius Life Science Corp | 71.47 Million TWD | 112.71% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 104.034% |
| GlycoNex Incorporation | 995 Thousand TWD | 1013.065% |
| GeneReach Biotechnology Corp. | 27.58 Million TWD | 132.936% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | 104.578% |
| SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | 1843.762% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 107.577% |
| Visgeneer Inc. | 67.48 Million TWD | 113.463% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 97.579% |
| Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 100.647% |
| G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | 106.283% |
| Neith Corporation | 18.01 Million TWD | 150.419% |
| Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 103.946% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 139.948% |
| Enimmune corporation | -23.37 Million TWD | 61.13% |
| TaiRx, Inc. | 2.43 Million TWD | 472.489% |
| EirGenix Inc. | 236.74 Million TWD | 103.838% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 108.706% |
| Sunny Pharmtech Inc. | 285.52 Million TWD | 103.182% |
| Lin BioScience, Inc. | -17.92 Million TWD | 49.322% |
| BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | 110.137% |
| Feng Chi Biotech Corp. | 80.72 Million TWD | 111.255% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | 938.873% |
| Lukas Biomedical Inc. | 133.89 Million TWD | 106.785% |
| RBC Bioscience Corporation | 72.89 Million TWD | 112.463% |
| BiOptic Inc. | 152.74 Million TWD | 105.948% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | 10194.444% |
| Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | 236.268% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | 447.419% |
| VBI | 16.42 Million TWD | 155.319% |
| CHO Pharma, Inc. | -28.27 Million TWD | 67.874% |
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | 2861.398% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 101.411% |
| Advagene Biopharma Co., Ltd. | -12 Million TWD | 24.304% |
| NaviFUS Corp. | 11.82 Million TWD | 176.816% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | 109.388% |
| Sinew Pharma Inc. | -28.98 Million TWD | 68.656% |
| Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | 3002.556% |
| Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 102.315% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 121.902% |
| AP Biosciences Inc | 32.25 Million TWD | 128.168% |
| Medigen Biotechnology Corp. | 617.32 Million TWD | 101.472% |
| 3D Global Biotech Inc. | 5.27 Million TWD | 272.26% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | 102.889% |
| Intech Biopharm Corporation | -163.99 Million TWD | 94.46% |
| Oneness Biotech Co., Ltd. | 32.56 Million TWD | 127.901% |
| Eusol Biotech Co.,Ltd. | -4.02 Million TWD | -125.49% |
| TWi Biotechnology, Inc. | -9.73 Million TWD | 6.715% |
| Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 101.874% |
| TCI GENE Inc. | 174.61 Million TWD | 105.203% |
| MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 45.274% |
| Senhwa Biosciences, Inc. | -10.17 Million TWD | 10.695% |
| Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | 111.898% |
| NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | 111.804% |
| PharmaEngine, Inc. | 718.97 Million TWD | 101.264% |
| Savior Lifetec Corporation | 220.94 Million TWD | 104.112% |
| TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | 108.134% |
| OBI Pharma, Inc. | -73.49 Million TWD | 87.639% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 106.542% |
| Acepodia, Inc. | 16.59 Million TWD | 154.752% |
| Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | 133.074% |